CHRNA7 and early-onset autosomal dominant Alzheimer disease: The α7 nicotinic acetylcholine receptor (nAChR) signaling is at the center of a number of diseases including schizophrenia, Alzheimer's disease, chronic pain and inflammatory diseases (69).